Error in the Conflict of Interest Disclosures
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical industry and healthcare · Medical Malpractice and Liability Issues · Pharmacovigilance and Adverse Drug Reactions
In the Original Investigation titled “Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy,” published on April 7, 2025, in the Conflict of Interest Disclosures, the grant number RR190079 was added for Cancer Prevention and Research Institute of Texas Scholar in Cancer Research for Dr Flowers. This article has been corrected online.^1^
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Long JP, Prakash R, Edelkamp P, ; Data-Driven Determinants for COVID-19 Discovery Effort (D 3CODE) Team. Cytokine storms in COVID-19, hemophagocytic lymphohistiocytosis, and CAR-T therapy. JAMA Netw Open. 2025;8(4):e 253455. doi:10.1001/jamanetworkopen.2025.345540193078 PMC 11976493 · doi ↗ · pubmed ↗